https://www.selleckchem.com/pr....oducts/befotertinib-
For , carriage prevalence was higher in the azithromycin arm for BM (13.8% versus 8.7%, 0.055) but not for VS or NPS. Prevalence of azithromycin resistant was higher in the azithromycin arm for BM (3.6% versus 1.0%, 0.05 and VS (1.5% versus 0% 0.057). Oral intrapartum azithromycin did not reduce carriage of and and was associated with an increase in the prevalence of azithromycin-resistant and isolates in BM and VS. Oral intrapartum azithromycin did not reduce carriage of E. coli and K. pneumoniae and was associated with
Like
Comment
Share
